Hypersensitivity of Ku-deficient cells toward the DNA topoisomerase II inhibitor ICRF-193 suggests a novel role for Ku antigen during the G2 and M phases of the cell cycle.

Source:http://linkedlifedata.com/resource/pubmed/id/9742097

Download in:

View as

General Info

PMID
9742097